News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Hernday Natasha
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 05/19/2023 |
4
| Hernday Natasha (Director) has filed a Form 4 on XOMA Corp|
Txns:
| Granted 10,967 options to buy
@ $21.39, valued at
$234.6k
|
|
| 01/05/2023 |
4
| Hernday Natasha (Director) has filed a Form 4 on ALPINE IMMUNE SCIENCES, INC.|
Txns:
| Granted 10,000 options to buy
@ $0 |
|
| 05/20/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/04/2022 |
4
| Hernday Natasha (Director) has filed a Form 4 on ALPINE IMMUNE SCIENCES, INC.|
Txns:
| Granted 10,000 options to buy
@ $0 |
|
| 05/21/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/05/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/17/2020 |
4
| Hernday Natasha (Director) has filed a Form 4 on XOMA Corp|
Txns:
| Granted 4,000 shares
@ $25, valued at
$100k
|
|
| 12/11/2020 |
4
| Hernday Natasha (Director) has filed a Form 4 on ALPINE IMMUNE SCIENCES, INC.|
Txns:
| Granted 15,000 options to buy
@ $11.07, valued at
$166.1k
|
|
| 12/11/2020 |
3
| Hernday Natasha (Director) has filed a Form 3 on ALPINE IMMUNE SCIENCES, INC. |
| 08/24/2020 |
4
| Hernday Natasha (Director) has filed a Form 4 on PDL BIOPHARMA, INC.|
Txns:
| Granted 25,826 shares
@ $0
Granted 118,671 options to buy
@ $3.63, valued at
$430.8k
|
|
| 07/02/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/02/2020 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
|
|